Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-21-055685

Director sold 19,109 shares at $16.74 ($319,976)

  • Director acquired 19,109 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Mitchell Stephen Ray · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-09 Exercise or conversion : show line 1 in the form +5,985 $10.57 $63,261 15,200 D
2021-09-09 Exercise or conversion : show line 2 in the form +13,124 $12.70 $166,675 28,324 D
2021-09-09 Sale : show line 3 in the form −19,109 $16.74 $319,976 9,215 D
Open-market sales · 19,109 sh · avg $16.74 · $319,976

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-09-09 Exercise or conversion : show line 4 in the form Stock Option (right to buy) −5,985 0 D
2021-09-09 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −13,124 21,876 D
Loading xslF345X03/doc4.xml…